Evidence map›Paper›PMID 25995874›Full record

ArticleActa crystallographica. Section E, Crystallographic communications2015

Crystal structure of bis-[4-(1H-pyrrol-1-yl)phen-yl] ferrocene-1,1'-di-carboxyl-ate: a potential chemotherapeutic drug.

Wanda I Pérez, Arnold L Rheingold, Enrique Meléndez

Open access · goldAbstract read
In one paragraph

Article in Acta crystallographica. Section E, Crystallographic communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Synthesis and crystal structures of 2-(ferrocenyl-carbon-yl)benzoic acid and 3-ferrocenylphthalide.Acta crystallographica. Section E, Crystallographic communications · 2020
    Article
  2. Crystal structure of 1,1'-bis-(2-meth-oxy-carbonyl-2-methyl-prop-yl)ferrocene.Acta crystallographica. Section E, Crystallographic communications · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Wanda I PérezUniversity of Puerto Rico, Department of Chemistry, PO Box 9019, Mayaguez, Puerto Rico 00681, USA.
Arnold L RheingoldUniversity of California-San Diego, Department of Chemistry, Urey Hall 5128, 9500 Gilman Drive, La Jolla, CA 92093-0358, USA.
Enrique MeléndezUniversity of Puerto Rico, Department of Chemistry, PO Box 9019, Mayaguez, Puerto Rico 00681, USA.
University of Puerto Rico-Mayaguez · PRUniversity of California, San Diego · US

Funding

RISE Enhancing Biomedical Sciences and Biomedical Engineering in Science and TechR25GM088023 · NIGMS · UNIVERSITY OF PUERTO RICO MAYAGUEZ · PI LOPEZ-GARRIGA, JUAN · 2010 to 2013
$5.0M
NIGMS NIH HHS R25 GM088023
6 · The paper itself

Abstract

The title iron(II) complex, [Fe(C16H12NO2)2], crystallizes in the ortho-rhom-bic space group Pbca with the Fe(2+) cation positioned on an inversion center. The cyclo-penta-dienyl (Cp) rings adopt an anti conformation in contrast with other substituted ferrocenes in which the Cp rings appear in a nearly eclipsed conformation. The Cp and the aromatic rings are positioned out of the plane, with a twist angle of 70.20 (12)°, and the C(Cp)-C(CO) bond length is shorter than a typical C-C single bond, which suggests a partial double-bond character and delocalization with the Cp π system. The structure of the complex is compared to other functionalized ferrocenes synthesized in our laboratory.

Indexed as

anti­proliferativechemotherapeutic drugcrystal structuredisubstituted ferroceneMCF-7pyrrole

Identifiers

PMID25995874
PMCPMC4420060
OpenAlexW247887075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.